AAAAAA

   
Results: 1-10 |
Results: 10
Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and-2
Authors: Benedict, CA Norris, PS Prigozy, TI Bodmer, JL Mahr, JA Garnett, CT Martinon, F Tschopp, J Gooding, LR Ware, CF
Citation: Ca. Benedict et al., Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and-2, J BIOL CHEM, 276(5), 2001, pp. 3270-3278
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
Authors: Holler, N Zaru, R Micheau, O Thome, M Attinger, A Valitutti, S Bodmer, JL Schneider, P Seed, B Tschopp, J
Citation: N. Holler et al., Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule, NAT IMMUNOL, 1(6), 2000, pp. 489-495
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Authors: Bodmer, JL Holler, N Reynard, S Vinciguerra, P Schneider, P Juo, P Blenis, J Tschopp, J
Citation: Jl. Bodmer et al., TRAIL receptor-2 signals apoptosis through FADD and caspase-8, NAT CELL BI, 2(4), 2000, pp. 241-243
Loss of caspase-8 expression in neuroblastoma is related to malignancy andresistance to TRAIL-induced apoptosis
Authors: Hopkins-Donaldson, S Bodmer, JL Bourloud, KB Brognara, CB Tschopp, J Gross, N
Citation: S. Hopkins-donaldson et al., Loss of caspase-8 expression in neuroblastoma is related to malignancy andresistance to TRAIL-induced apoptosis, MED PED ONC, 35(6), 2000, pp. 608-611
Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors
Authors: Holler, N Kataoka, T Bodmer, JL Romero, P Romero, J Deperthes, D Engel, J Tschopp, J Schneider, P
Citation: N. Holler et al., Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors, J IMMUNOL M, 237(1-2), 2000, pp. 159-173
The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation
Authors: Muhlenbeck, F Schneider, P Bodmer, JL Schwenzer, R Hauser, A Schubert, G Scheurich, P Moosmayer, D Tschopp, J Wajant, H
Citation: F. Muhlenbeck et al., The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation, J BIOL CHEM, 275(41), 2000, pp. 32208-32213
Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL
Authors: Bodmer, JL Meier, P Tschopp, J Schneider, P
Citation: Jl. Bodmer et al., Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL, J BIOL CHEM, 275(27), 2000, pp. 20632-20637
Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)
Authors: Kaptein, A Jansen, M Dilaver, G Kitson, J Dash, L Wang, E Owen, MJ Bodmer, JL Tschopp, J Farrow, SN
Citation: A. Kaptein et al., Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3), FEBS LETTER, 485(2-3), 2000, pp. 135-141
Loss of caspase-8 expression in highly malignant human neuroblastoma cellscorrelates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
Authors: Hopkins-Donaldson, S Bodmer, JL Bourloud, KB Brognara, CB Tschopp, J Gross, N
Citation: S. Hopkins-donaldson et al., Loss of caspase-8 expression in highly malignant human neuroblastoma cellscorrelates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis, CANCER RES, 60(16), 2000, pp. 4315-4319
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth
Authors: Schneider, P MacKay, F Steiner, V Hofmann, K Bodmer, JL Holler, N Ambrose, C Lawton, P Bixler, S Acha-Orbea, H Valmori, D Romero, P Werner-Favre, C Zubler, RH Browning, JL Tschopp, J
Citation: P. Schneider et al., BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth, J EXP MED, 189(11), 1999, pp. 1747-1756
Risultati: 1-10 |